Chromadex Corp CS (CDXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CDXC | AMGN | GILD | CELG | VRTX |
| Company | Chromadex Corp CS | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.38 | 265.72 | 65.50 | 108.01 | 393.52 |
| High | 3.52 | 271.68 | 66.35 | 108.59 | 399.68 |
| Low | 3.38 | 265.72 | 64.63 | 107.27 | 393.49 |
| Last | 3.44 | 269.98 | 65.42 | 108.24 | 397.48 |
| Change | +0.05 | +0.60 | +0.15 | +0.11 | -0.22 |
| % Change | +1.47% | +0.22% | +0.23% | +0.10% | -0.06% |
| Volume | 180,200 | 2,436,900 | 12,380,800 | 191,230,496 | 682,400 |
| 20-Day Average Volume | 379,990 | 2,156,940 | 7,062,310 | 16,188,930 | 943,625 |
| Previous Close | 3.39 | 269.38 | 65.27 | 108.13 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.77 | 269.99 | 68.29 | 108.17 | 401.28 |
| 20-Day Raw Stochastic | 31.25% | 40.03% | 9.20% | 63.25% | 21.25% |
| 20-Day Relative Strength | 53.61% | 45.47% | 29.21% | 64.69% | 42.53% |
| Weighted Alpha | +94.56 | +9.45 | -23.49 | +46.30 | +14.78 |
| Today's Opinion | 80% Buy | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 80% Buy | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.78% since 04/19/24 | +0.39% since 04/19/24 | -2.01% since 04/19/24 | -1.97% since 11/13/19 | +0.81% since 04/19/24 |
| Low | 2.89 on 04/22/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 393.00 on 04/25/24 |
| High | 3.72 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -10.42% since 03/26/24 | -4.18% since 03/26/24 | -9.65% since 03/26/24 | +5.14% since 10/18/19 | -5.01% since 03/26/24 |
| Low | 2.89 on 04/22/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 4.65 on 04/05/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +124.84% since 01/26/24 | -13.40% since 01/26/24 | -17.73% since 01/26/24 | +13.63% since 08/20/19 | -7.60% since 01/26/24 |
| Low | 1.46 on 02/12/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 4.65 on 04/05/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +160.61% since 10/26/23 | +0.10% since 10/26/23 | -16.66% since 10/26/23 | +14.14% since 05/20/19 | +10.02% since 10/26/23 |
| Low | 1.28 on 11/01/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 4.65 on 04/05/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 255,297 | 144,488,960 | 81,266,176 | 77,035,920 | 102,789,152 |
| Shares Outstanding, K | 75,309 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 83,570,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -4,940,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 21,200,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 110,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.99 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/06/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 29.82 |